These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3133189)

  • 21. Estrogen supplementation for bone dematuration in young epileptic man treated with anticonvulsant therapy; a case report.
    Yamano Y; Sakane S; Takamatsu J; Ohsawa N
    Endocr J; 1999 Apr; 46(2):301-7. PubMed ID: 10460015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiologic bone changes and hypocalcemia with anticonvulsant therapy in epilepsy.
    Sotaniemi EA; Hakkarainen HK; Puranen JA; Lahti RO
    Ann Intern Med; 1972 Sep; 77(3):389-94. PubMed ID: 4262314
    [No Abstract]   [Full Text] [Related]  

  • 23. Skeletal status in mentally retarded patients on anticonvulsive therapy.
    Vose GP; Rawley R; Ashby J
    Growth; 1977 Sep; 41(3):161-9. PubMed ID: 914050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential effects of valproate and oxcarbazepine on growth velocity and bone metabolism in epileptic children- a medical center experience.
    Lin CM; Fan HC; Chao TY; Chu DM; Lai CC; Wang CC; Chen SJ
    BMC Pediatr; 2016 May; 16():61. PubMed ID: 27142370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6.
    Sener U; Zorlu Y; Karaguzel O; Ozdamar O; Coker I; Topbas M
    Seizure; 2006 Mar; 15(2):79-85. PubMed ID: 16414291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone status after long-term anticonvulsant therapy in epileptic patients: evaluation using quantitative ultrasound of calcaneus and phalanges.
    Pluskiewicz W; Nowakowska J
    Ultrasound Med Biol; 1997; 23(4):553-8. PubMed ID: 9232764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer among epileptic patients exposed to anticonvulsant drugs.
    Olsen JH; Boice JD; Jensen JP; Fraumeni JF
    J Natl Cancer Inst; 1989 May; 81(10):803-8. PubMed ID: 2716074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A quantitative determination of anticonvulsant-induced bone demineralization by an improved X-ray densitometry technique.
    Wolschendorf K; Vanselow K; Möller WD; Schulz H
    Neuroradiology; 1983; 25(5):315-8. PubMed ID: 6646409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total cholesterol, high-density lipoprotein cholesterol, and triglycerides in children receiving antiepileptic drugs.
    Franzoni E; Govoni M; D'Addato S; Gualandi S; Sangiorgi Z; Descovich GC; Salvioli GP
    Epilepsia; 1992; 33(5):932-5. PubMed ID: 1396438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum vitamin D metabolites in epileptic patients treated with 2 different anti-convulsants.
    Tjellesen L; Christiansen C
    Acta Neurol Scand; 1982 Sep; 66(3):335-41. PubMed ID: 6982586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rickets in children receiving anticonvulsant drugs. Biochemical and hormonal markers.
    Winnacker JL; Yeager H; Saunders JA; Russell B; Anast CS
    Am J Dis Child; 1977 Mar; 131(3):286-90. PubMed ID: 842513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders.
    Otoom S; Bakhiet M; Khan A; Sequeira R
    Neuro Endocrinol Lett; 2006; 27(1-2):85-8. PubMed ID: 16648782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of chronic anticonvulsant therapy on serum lipids and lipoproteins in epileptic children.
    Heldenberg D; Harel S; Holtzman M; Levtow O; Tamir I
    Neurology; 1983 Apr; 33(4):510-13. PubMed ID: 6403892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zinc status and delayed cutaneous hypersensitivity in handicapped children treated with anticonvulsants.
    Higashi A; Chen C; Matsuda I
    Dev Pharmacol Ther; 1987; 10(1):30-5. PubMed ID: 2953582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum zinc and vitamin E concentrations in handicapped children treated with anticonvulsants.
    Higashi A; Ikeda T; Matsukura M; Matsuda I
    Dev Pharmacol Ther; 1982; 5(3-4):109-13. PubMed ID: 6217962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for hyperammonemia in pediatric patients with epilepsy.
    Yamamoto Y; Takahashi Y; Imai K; Mishima N; Yazawa R; Inoue K; Itoh K; Kagawa Y; Inoue Y
    Epilepsia; 2013 Jun; 54(6):983-9. PubMed ID: 23409971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folic acid deficiency from anticonvulsant therapy.
    Gordon N
    Dev Med Child Neurol; 1968 Aug; 10(4):497-504. PubMed ID: 5681561
    [No Abstract]   [Full Text] [Related]  

  • 38. Anticonvulsants, folic acid and memory dysfunction in epileptics.
    Butlin AT; Danta G; Cook ML
    Clin Exp Neurol; 1984; 20():57-62. PubMed ID: 6439448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. American Academy of Pediatrics. Behavioral and cognitive effects of anticonvulsant therapy. Committee on Drugs.
    Pediatrics; 1985 Oct; 76(4):644-7. PubMed ID: 3931047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children.
    Herranz JL; Armijo JA; Arteaga R
    Epilepsia; 1988; 29(6):794-804. PubMed ID: 3142761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.